Sponsor Pipeline

Guy Boeckxstaens Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT07655375
Study Evaluating the Effect of UCB8600 on Mast Cell Activation in the Human Gut		 Recruitment opened
Active Trials by Phase
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05815602 Ebastine Versus Mebeverine in IBS Patients IBS - Irritable Bowel Syndrome Recruiting
Not specified
NCT07655375 Study Evaluating the Effect of UCB8600 on Mast Cell Activation in the Human Gut IBS (Irritable Bowel Syndrome) Recruiting
Get alerts when Guy Boeckxstaens's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free